China greenlights two ChiNext IPOs

BEIJING, June 13 (Xinhua) -- China's securities regulator has approved the initial public offering (IPO) registration of two companies on the country's NASDAQ-style ChiNext board.

R&G PharmaStudies Co., Ltd., and Wintao Communications Co., Ltd. will be listed on the Shenzhen Stock Exchange's board of growth enterprises, the ChiNext board, according to the China Securities Regulatory Commission.

The companies should strictly follow the prospectuses as well as the issuance and underwriting plans while issuing stocks, the commission said.

Reading:

Economic Watch: Shanghai's financial operations stable despite epidemic

【Financial Str. Release】Overseas investors optimistic about China’s A-share market in the mid-, long-term

China greenlights IPO registration on Nasdaq-style board

Chinese oil giant CNOOC made a record-breaking debut in Shanghai

【Financial Str. Release】CSRC to steadily advance full-scale registration-based IPO reform